Author:
Habal Nizar,Gupta Rishab K.,Bilchik Anton J.,Yee Reynold,Leopoldo Zacharias,Ye Wei,Elashoff Robert M.,Morton Donald L.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Hoon DSB, Irie RF. Current status of human melanoma vaccines: Can they control malignant melanoma? BioDrugs 1997; 7: 66?84.
2. Morton DL, Foshag LJ, Hoon DSB, et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992; 216: 463?82.
3. Morton DL, Hoon DSB, Nizze JA, et al. Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma. Ann N Y Acad Sci 1993; 690: 120?34.
4. Takahashi T, Johnson TD, Nishinaka Y, Morton DL, Irie RF. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J Invest Dermatol 1999; 112: 101?5.
5. Hoon DSB, Morisaki T, Uchiyama A, et al. Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens. Ann N Y Acad Sci 1993; 690: 343?5.
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献